Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von CandyButcher 

Merck & Co. Inc. diskutieren

Merck & Co. Inc.

WKN: A0YD8Q / Symbol: MRK / Name: Merck & Co / Aktie / Pharmazeutika / Large Cap /

114,24 €
1,10 %

Einschätzung Buy
Rendite (%) 1,05 %
Kursziel 123,70
Veränderung
Endet am 30.06.27

Merck & Co., Inc. (MRK) had its price target raised by Bank of America Corporation from $130.00 to $141.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 2,56 %
Kursziel 124,38
Veränderung
Endet am 08.07.27

Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 5,37 %
Kursziel 127,24
Veränderung
Endet am 13.07.27

Merck & Co., Inc. (MRK) had its price target raised by Guggenheim from $140.00 to $145.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,69 %
Kursziel 124,61
Veränderung
Endet am 13.07.27

Merck & Co., Inc. (MRK) had its price target raised by BMO Capital Markets from $135.00 to $142.00. They now have an "outperform" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 4,86 %
Kursziel 122,85
Veränderung
Endet am 13.07.27

Merck & Co., Inc. (MRK) had its price target raised by JPMorgan Chase & Co. from $135.00 to $140.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) -2,13 %
Kursziel 131,63
Veränderung
Endet am 29.07.27

Merck & Co., Inc. (MRK) had its price target raised by Barclays PLC from $140.00 to $150.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,93 %
Kursziel 126,55
Veränderung
Endet am 05.08.27

Merck & Co., Inc. (MRK) had its price target raised by Guggenheim from $145.00 to $146.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,71 %
Kursziel 125,58
Veränderung
Endet am 11.08.27

Merck & Co., Inc. (MRK) had its price target raised by Argus from $130.00 to $145.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat

Einschätzung Buy
Rendite (%) 1,39 %
Kursziel 123,95
Veränderung
Endet am 12.08.27

Merck & Co., Inc. (MRK) was upgraded by Daiwa Securities Group Inc. from "neutral" to "outperform". They now have a $143.00 price target on the stock.
Ratings data for MRK provided by MarketBeat